First Thing, Daily Maverick's flagship newsletter

Join the 230 000 South Africans who read First Thing newsletter.

We'd like our readers to start paying for Daily Maverick

More specifically, we'd like those who can afford to pay to start paying. What it comes down to is whether or not you value Daily Maverick. Think of us in terms of your daily cappuccino from your favourite coffee shop. It costs around R35. That’s R1,050 per month on frothy milk. Don’t get us wrong, we’re almost exclusively fuelled by coffee. BUT maybe R200 of that R1,050 could go to the journalism that’s fighting for the country?

We don’t dictate how much we’d like our readers to contribute. After all, how much you value our work is subjective (and frankly, every amount helps). At R200, you get it back in Uber Eats and ride vouchers every month, but that’s just a suggestion. A little less than a week’s worth of cappuccinos.

We can't survive on hope and our own determination. Our country is going to be considerably worse off if we don’t have a strong, sustainable news media. If you’re rejigging your budgets, and it comes to choosing between frothy milk and Daily Maverick, we hope you might reconsider that cappuccino.

We need your help. And we’re not ashamed to ask for it.

Our mission is to Defend Truth. Join Maverick Insider.

Support Daily Maverick→
Payment options

China stocks log best month in 2 years on recovery hope...



China stocks log best month in 2 years on recovery hopes, easing Covid-19 curbs

People cross a road in the Central Business District (CBD) area in Beijing, China, 30 June 2022. EPA-EFE/WU HAO
By Reuters
30 Jun 2022 0

SHANGHAI, June 30 (Reuters) - China stocks marked their best month in nearly two years on Thursday, supported by signs of an economic recovery after the easing of COVID-19 restrictions.

However, in Hong Kong, the benchmark Hang Seng Index .HSI slipped 0.62% to 21,859.79 points at close, while Chinese H-shares listed in Hong Kong .HSCE edged down 0.36% to 7,666.88 points.

By the end of the session, Shanghai Composite index .SSEC rose 1.1% to 3,398.62 points, while blue-chip CSI300 index .CSI300 gained 1.44% to 4,485.01 points. Both indexes recorded their biggest monthly gains since July 2020.

Gains across the board came as official data showed that China’s factory and service sectors snapped three months of activity decline in June, as authorities lifted a strict COVID lockdown in Shanghai, reviving output and consumer spending.

China’s central bank needs to keep cuts to interest rates and banks’ reserve requirement ratio among its policy options while waiting for the economy to bounce back, said Guan Tao, a former senior official at the country’s foreign exchange regulator.

Analysts said hopes for more stimulus measures, including monetary easing, continued to lend support to markets.

“In the early stage of economic recovery, regardless of the pace of growth, monetary policy at least favours an easing bias,” said Zhang Jingjing, chief macro analyst at China Merchants Securities.

The latest easing of coronavirus travel rules combined with other encouraging policy signals have begun to lure some foreign investors back to Chinese stocks, raising the chances that the market can sustain its bounce after months of heavy selling.

Official data showed that foreign investors bought 139.15 billion yuan ($20.79 billion) of China stocks this month through the Stock Connect scheme, the most this year.

Tourism and liquor sectors were among the biggest winners as easing coronavirus restrictions boosted investor sentiment. An index tracking tourism-related companies .CSI930633 jumped 4.1% at close.

CSI liquor .CSI399997, a gauge that measures the performance of spirits producers, rose 3.74% on Thursday. Wuliangye Yibin Co Ltd 000858.SZ jumped 5.17% to 201.93 yuan, while Kweichow Moutai 600519.SS surged 1.83% to 2,045 yuan at the close.

(Reporting by the Shanghai Newsroom; Editing by Sherry Jacob-Phillips and Amy Caren Daniel)


"Information pertaining to Covid-19, vaccines, how to control the spread of the virus and potential treatments is ever-changing. Under the South African Disaster Management Act Regulation 11(5)(c) it is prohibited to publish information through any medium with the intention to deceive people on government measures to address COVID-19. We are therefore disabling the comment section on this article in order to protect both the commenting member and ourselves from potential liability. Should you have additional information that you think we should know, please email [email protected]"

Please peer review 3 community comments before your comment can be posted